• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

You Heard It Here First...

Another idiot that is just doesn’t get strategy. There will be NSS and GI and PC. The primary care will have trintellix along with Dex and AMI. They will still not call on psych specialty only primary care.This is how it will be until Late 2020/ early 2021. Ami and Dex will go and then them PC reps will pick up Shires GI drug and take over growing it in primary care.


Wait? Except the new Shire drug was just approved and is ready to be launched for CIC...Sooooo NOT selling Trintellix makes more sense. BUT to slot in more NSS to pick up high prescribers and pysch's in rural areas DOES.. It's called critical thinking...
 




Wait? Except the new Shire drug was just approved and is ready to be launched for CIC...Sooooo NOT selling Trintellix makes more sense. BUT to slot in more NSS to pick up high prescribers and pysch's in rural areas DOES.. It's called critical thinking...

You obviously weren’t on the email that states who will be selling the new CIC drug.